GleamWall
中文EN

OFIX Orthofix Medical Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 884624 · Fiscal year ends 12/23

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.1%
TTM net income YoY62.2%
TTM EPS YoY63.7%
Revenue 3-yr CAGR7.7%
Net income 3-yr CAGR—

Margins

Gross margin70.9%
Operating margin-2.5%
Net margin-5.4%
FCF margin-5.3%
EBITDA margin3.9%

Returns

ROE-10.3%
ROA-5.3%
ROIC (approx.)-2.9%
Asset turnover0.99x

Leverage & solvency

Liabilities / assets49.8%
Debt / equity0.52x
Current ratio3.11x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.09x
Accruals ratio-5.8%
Payout ratio—
Capex / revenue5.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$207.86M$210.93M$196.71M$219.91M$205.63M$203.12M$193.65M$215.66M
Cost of revenue$61.32M$61.23M$57.16M$63.57M$57.11M$63.59M$72.03M$66.82M
Gross profit$146.55M$149.71M$139.55M$156.34M$148.52M$139.53M$121.62M$148.84M
R&D expense$15.28M$15.94M$15.32M$15.37M$14.77M$15.93M$19.77M$18.81M
SG&A expense$125.33M$138.03M$134.91M$136.75M$148.10M$136.49M$132.98M$433.32M
Operating income$1.54M-$8.13M-$14.44M$494,000-$17.05M-$16.00M-$48.87M-$11.48M
Pretax income-$5.25M-$15.00M-$20.83M-$2.19M-$22.26M-$14.22M-$52.13M-$29.71M
Income tax$826,000$801,000$74,000$30,000$533,000-$142,000$961,000-$564,000
Net income-$6.07M-$15.80M-$20.91M-$2.22M-$22.80M-$14.08M-$53.09M-$29.15M
EBITDA$14.72M$5.14M-$943,000$13.57M-$4.11M$868,000-$14.44M$4.52M
EPS (basic)-0.15-0.39-0.52—-0.57-0.36-1.35—
EPS (diluted)-0.15-0.39-0.52—-0.57-0.36-1.35—
Weighted avg. shares (diluted)41.18M40.91M40.45M—39.77M39.50M39.19M—
Banking
Net interest income-$5.89M-$6.08M-$5.66M-$4.35M-$4.68M-$3.95M-$4.51M-$14.92M
Provision for credit losses$1.24M$2.87M$719,000-$211,000$629,000$779,000$1.06M-$60,000
Balance sheet
Cash & equivalents$86.32M$103.81M$120.28M$82.03M$62.86M$65.61M$57.95M$83.24M
Receivables$131.72M$135.82M$137.78M$135.75M$130.81M$129.56M$131.87M$134.71M
Inventory$190.36M$184.47M$177.82M$172.32M$174.04M$172.99M$174.48M$189.45M
Current assets$430.79M$446.13M$461.52M$416.85M$394.17M$395.83M$390.31M$433.29M
PP&E, net$133.39M$130.76M$125.33M$129.40M$130.02M$129.20M$130.69M$139.80M
Goodwill$194.93M$194.93M$194.93M$194.93M$194.93M$194.93M$194.93M$194.93M
Intangibles$62.90M$65.97M$69.34M$72.77M$75.64M$78.87M$81.21M$98.80M
Total assets$855.76M$873.02M$886.60M$850.65M$832.61M$837.16M$823.14M$893.29M
Current liabilities$138.38M$157.01M$161.03M$170.48M$159.85M$148.38M$144.12M$168.63M
Short-term debt———$0———$0
Long-term debt$221.85M$221.59M$221.34M$157.39M$157.22M$157.05M$156.88M$157.01M
Total debt$221.85M$221.59M$221.34M$157.39M$157.22M$157.05M$156.88M$157.01M
Total liabilities$426.19M$443.84M$451.42M$400.61M$390.12M$378.81M$364.85M$390.17M
Shareholders' equity$429.57M$429.18M$435.19M$450.04M$442.49M$458.35M$458.29M$503.12M
Net debt$135.53M$117.78M$101.06M$75.37M$94.36M$91.44M$98.93M$73.78M
Shares outstanding40.75M40.73M40.38M39.83M39.52M39.48M39.10M38.49M
Cash flow statement
Operating cash flow$363,000-$6.22M-$17.61M$27.70M$12.40M$11.64M-$18.39M$23.73M
Capital expenditure$14.50M$12.65M$10.66M$10.88M$9.90M$7.11M$6.74M$9.67M
Free cash flow-$14.14M-$18.87M-$28.27M$16.82M$2.50M$4.53M-$25.13M$14.06M
Investing cash flow-$14.50M-$12.65M-$10.52M-$10.87M-$9.89M-$7.10M-$6.74M-$1.14M
Financing cash flow-$3.19M$2.45M$63.97M$2.38M-$5.15M$2.64M-$651,000$31.49M
Depreciation & amortization$13.17M$13.27M$13.49M$13.08M$12.94M$16.87M$34.43M$15.99M
Stock-based compensation$6.74M$7.74M$6.53M$7.21M$7.18M$7.82M$6.47M$7.17M

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.